Anthem is striving to become a digital AI-first enterprise and make healthcare far more predictive, far more proactive, transparent, and personalized than it currently is.
Read More
Data gathering is not a problem in COVID-19 race towards a reliable vaccine. The challenge is how to evaluate it, says Glen de Vries, Co-Founder and Co-CEO of Medidata. End of July Medidata started working with Moderna to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.
Read More
ClinicalTrials.gov currently lists 302,091 clinical studies in the US. It is impossible for patients and their doctors to be aware of all clinical trials an individual might be eligible for. The data issues surrounding clinical trials don’t end there: how can we rely on results of trials when studies with negative results often go unpublished? Various companies are creating platforms and solutions to address these issues.
Read More
The way we view data today is going to radically change in terms of ownership, says Ray. In the future, we will have more autonomy and will not to have to give away our data ownerships right to intermediaries. Until we get there though, one of the key things blockchain solutions need to figure out is the user experience and managing private keys.
Read More